These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1948364)

  • 1. [The immunological characteristics of metatypic skin cancer].
    Snarskaia ES
    Sov Med; 1991; (7):90. PubMed ID: 1948364
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immuno-allergological studies in skin cancer].
    Michailow P; Berowa N; Kutintschev M
    Hautarzt; 1966 Aug; 17(8):356-7. PubMed ID: 4965047
    [No Abstract]   [Full Text] [Related]  

  • 3. T lymphocytes with Fc-IgG receptors in skin cancers.
    Vena GA; Angelini G; D'Ovidio R; Lospalluti M; Meneghini CL
    Acta Derm Venereol; 1981; 61(6):555-8. PubMed ID: 6177170
    [No Abstract]   [Full Text] [Related]  

  • 4. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
    Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
    Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNCB reactivity in patients with skin carcinoma.
    Bleumink E; Nater JP
    Dermatologica; 1974; 148(1):44-6. PubMed ID: 4364858
    [No Abstract]   [Full Text] [Related]  

  • 6. The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients.
    Durando B; Reichel J
    Dermatol Ther; 2005; 18(1):1-11. PubMed ID: 15842607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-induced angiogenesis assay--in cutaneous malignancies and cutaneous and genital warts.
    Szmurło A; Grzesik W
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):85-7. PubMed ID: 2466452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of urocanic acid isomers in human basal and squamous cell carcinoma tumors compared with tumor periphery and healthy skin.
    Decara JM; Aguilera J; Abdala R; Sánchez P; Figueroa FL; Herrera E
    Exp Dermatol; 2008 Oct; 17(10):806-12. PubMed ID: 18312386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
    Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple cutaneous carcinomas and lymphomas of the skin.
    Cohen C
    Arch Dermatol; 1980 Jun; 116(6):687-9. PubMed ID: 6892866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin tumors and reactive cellular infiltrate: further studies.
    Claudatus JC; d'Ovidio R; Lospalluti M; Meneghini CL
    Acta Derm Venereol; 1986; 66(1):29-34. PubMed ID: 2424211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-specific serum antibodies are not associated with a history of skin carcinoma in renal transplant recipients and immunocompetent individuals.
    de Graaf YG; Schiefer D; Redeker A; Vermeer BJ; Bavinck JN; Willemze R; de Gruijl FR; Van der Burg SH
    J Dermatol Sci; 2005 Jun; 38(3):228-30. PubMed ID: 15927816
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of a number of nutritional and immunological indices in patients with skin carcinoma.
    Moriarty M; O'Loughlin G; McFarlane R; Johnson A; Collins P; Mulgrew S; Conroy R; Daly L
    Ir J Med Sci; 1983 Jun; 152(6):242-5. PubMed ID: 6874293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cross-reacting antigen common to stratified squamous epithelium and Streptococcus group A in tumors of epidermal origin].
    Silagadze DG; Beletskaia LV; Berenbein VA; Kolesnikova VIu
    Vopr Onkol; 1981; 27(6):27-32. PubMed ID: 7023039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple nonmelanoma skin cancer associated with HLA DR7 in southern Australia.
    Czarnecki DB; Lewis A; Nicholson I; Tait B
    Cancer; 1991 Jul; 68(2):439-40. PubMed ID: 2070340
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bound IgG, IgM, IgA and complement in the epidermis of the growth zone of skin tumors].
    Beletskaia LV; Berenbeĭn BA; Silagadze DG; Ezhov NIa
    Vestn Dermatol Venerol; 1981 Jan; (1):13-6. PubMed ID: 7210863
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune response to basal cell and squamous cell carcinomas.
    Grimwood RE
    Immunol Ser; 1989; 46():789-98. PubMed ID: 2488879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
    Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
    Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
    Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
    Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.